pennpursuit3reel| U.S. stocks change| Lilly rose by more than 4% to record a record high of tilpositide injection approved in China

Lillypennpursuit3reel.US) rose more than 4%pennpursuit3reel, the highest hit 816pennpursuit3reel.61 dollarspennpursuit3reel, setting a new high since listing. On the news front, on May 21, the official website of the State Food and Drug Administration showed that Lilly Mofonda (tierpositide injection) was approved by the State Food and Drug Administration (NMPA) to improve blood sugar control in adult patients with type 2 diabetes. Tilpositide is a GIPR and GLP-1R agonist injected once a week.